PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas

Soft-tissue sarcomas (STS) are a group of rare, heterogeneous, and aggressive tumors, with high metastatic risk and relatively few efficient systemic therapies. In the quest for new treatments, the immune system represents an attractive therapeutic target. Recently, PD1/PDL1 inhibitors showed very p...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncoimmunology
Hlavní autoři: Bertucci, François, Finetti, Pascal, Perrot, Delphine, Leroux, Agnès, Collin, Françoise, Le Cesne, Axel, Coindre, Jean-Michel, Blay, Jean-Yves, Birnbaum, Daniel, Mamessier, Emilie
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2017
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5384364/
https://ncbi.nlm.nih.gov/pubmed/28405501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1278100
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky